$DXCM

$78.57 +$0.63 (0.81%) Close

$DXCM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$DXCM Management Team

Mr. Jacob Leach

President

Interim Principal Executive Officer

Chief Operating Officer

Age 47

Compensation $5.922M USD

Sex Male

Mr. Jereme Sylvain

Chief Financial Officer

Executive Vice President

Age 45

Compensation $5.851M USD

Sex Male

Ms. Sadie Stern

Chief Human Resources Officer

Executive Vice President

Age 50

Compensation $4.908M USD

Sex Female

Mr. Mark Foletta

Interim Independent Chairman of the Board

Age 64

Compensation $388.1K USD

Sex Male

Mr. Michael Brown

Executive Vice President

Chief Legal Officer

Age 55

Compensation $4.965M USD

Sex Male

Mr. Sean Christensen

Vice President - Finance and Investor Relations

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Jacob Leach President Interim Principal Executive Officer Chief Operating Officer	47	$5.922M USD	Male
Mr. Jereme Sylvain Chief Financial Officer Executive Vice President	45	$5.851M USD	Male
Ms. Sadie Stern Chief Human Resources Officer Executive Vice President	50	$4.908M USD	Female
Mr. Mark Foletta Interim Independent Chairman of the Board	64	$388.1K USD	Male
Mr. Michael Brown Executive Vice President Chief Legal Officer	55	$4.965M USD	Male
Mr. Sean Christensen Vice President - Finance and Investor Relations	-	-	Male

Board of Directors

From the proxy statement filed Apr 15, 2026

Directors

serving now

Independent

8 of 10

stated in the proxy; 2 not stated

Average tenure

7.3 years

from year joined

CEO also chairs the board

Kevin Sayer

Director	Age	On board	Independent	Committees	Other public boards	Pay
Steven Altman	64	2013 13 years	Independent	None stated	None stated	Not stated
Euan Ashley	54	2025 1 year	Independent	None stated	AstraZeneca Plc	Not stated
Nicholas Augustinos	67	2009 17 years	Independent	None stated	None stated	Not stated
Richard Collins	69	2017 9 years	Independent	None stated	None stated	Not stated
Rimma Driscoll	53	2023 3 years	Independent	None stated	None stated	Not stated
Mark Foletta Lead independent director	65	2014 12 years	Independent	None stated	AMN Healthcare Services	Not stated
Renée Galá	54	2025 1 year	Independent	None stated	Jazz Pharmaceuticals PLC	Not stated
Bridgette Heller	64	2019 7 years	Independent	None stated	Aramark	Not stated
Jacob Leach CEO	48	2026 0 years	Not independent	None stated	SenesTech, Inc.	Paid as CEO
Kyle Malady	59	2020 6 years	Not stated	None stated	None stated	Not stated
Rick Osterloh	53	2026 0 years	Not stated	None stated	None stated	Not stated
Kevin Sayer Board chair	68	2007 19 years	Not independent	None stated	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 15, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$DXCM Management Team

Mr. Jacob Leach

Mr. Jereme Sylvain

Ms. Sadie Stern

Mr. Mark Foletta

Mr. Michael Brown

Mr. Sean Christensen

Board of Directors

Related-party transactions

No related-party transactions disclosed